How are you using NGS and comprehensive genomic profiling in South Korea, and in which cancer subtypes are you using NGS to identify actionable molecular targets and targeted treatment strategies? (Korean)

How are you using NGS and comprehensive genomic profiling in South Korea, and in which cancer subtypes are you using NGS to identify actionable molecular targets and targeted treatment strategies? (Korean)

How are you using NGS and comprehensive genomic profiling in South Korea, and in which cancer subtypes are you using NGS to identify actionable molecular targets and targeted treatment strategies?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Seung Tae Kim, MD

Seung Tae Kim, MD

Division of Hematology Oncology
Department of Medicine
Samsung Medical Center
Sungkyunkwan University School of Medicine
Seoul, Korea